National Vision Holdings, Inc.
EYE$600M
Small CapNASDAQOphthalmic Goods🇺🇸North AmericaDULUTH
Drugs in Pipeline
3
Phase 3 Programs
3
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
EYE News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
Drug Pipeline
Inactivated SARS-CoV-2 Vaccine (Vero cell)
COVID-19
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed
Whooping Cough
SARS-CoV-2 Vaccine (Vero Cell), Inactivated
COVID-19 Pneumonia
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Inactivated SARS-CoV-2 Vaccine (Vero cell) | Phase 3 | COVID-19 | - | - |
Diphtheria,Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed | Phase 3 | Whooping Cough | - | - |
SARS-CoV-2 Vaccine (Vero Cell), Inactivated | Phase 3 | COVID-19 Pneumonia | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply